Litcius/Paper detail

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant

Meagan A. Quinlan, Matthew J. Robson, Ran Ye, Kristie L. Rose, Kevin L. Schey, Randy Blakely

2020Frontiers in Molecular Neuroscience29 citationsDOIOpen Access PDF

Abstract

Altered serotonin (5-HT) signaling is associated with multiple brain disorders, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and autism spectrum disorder (ASD). The presynaptic, high-affinity 5-HT transporter (SERT) tightly regulates 5-HT clearance after release from serotonergic neurons in the brain and enteric nervous systems, among other sites. Accumulating evidence suggests that SERT is dynamically regulated in distinct activity states as a result of environmental and intracellular stimuli, with regulation perturbed by disease-associated coding variants. Our lab identified a rare, hypermorphic SERT coding substitution, Gly56Ala, in subjects with ASD, finding that the Ala56 variant stabilizes a high-affinity outward-facing conformation, leading to elevated 5-HT uptake, termed SERT* state, in vitro and in vivo. Hyperactive SERT Ala56 appears to preclude further activity enhancements by p38 MAPK and can be normalized by pharmacological p38⍺ MAPK inhibition, consistent with SERT Ala56 mimicking, constitutively, a high-activity conformation entered into transiently by p38⍺ MAPK activation. As SERT has been found to interact with a number of regulatory proteins, we hypothesize that changes in SERT-interacting proteins (SIPs) support the shift of SERT into the SERT* state that can best be captured comparing SERT Ala56 protein complexes with those of wildtype SERT and by defining specific interactions through comparisons to protein complexes recovered in SERT-/- mice. Using quantitative proteomics-based approaches, we identify a number of proteins previously shown to interact with SERT, as well as a number of SIPs, that demonstrate both SERT specificity and sensitivity to the Gly56Ala substitution. Network analysis of our findings uncovers a number of ASD-associated proteins, consistent with long-standing evidence of serotonergic contributions to ASD. Further investigation of these SIPs, and the pathways they engage, may afford a greater understanding of ASD as well as other brain and peripheral disorders associated with perturbed 5-HT signaling.

Topics & Concepts

Serotonin transporterSerotonergicInteractomeSerotoninBiologySerotonin Plasma Membrane Transport ProteinsTransporterNeuroscienceBiochemistryGeneReceptorNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and SignalingPancreatic function and diabetes